Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 November 2019 | Story Valentino Ndaba | Photo Charl Devenish
SK Luwaca at UFS Safety Summit for off-campus students
Sikhululekile Luwaca, leader of the UFS Safety Champions, addresses a delegation at the Higher Education Safety Summit from 18-19 October 2019 at the Bloemfontein Campus.

A meeting of minds over student safety recently took place at Kovsies. The Higher Education Safety Summit saw a cohort of 165 students from the University of the Free State (UFS), Central University of Technology and Sol Plaatje University, collaborating with the heads of Protection Services from the respective institutions to devise a safety blueprint specifically focusing on the off-campus environment.

“The rental tribunal came on board to assist with rental disputes between students and landlords, in addition to accreditation issues being discussed,” Sikhululekile Luwaca, former SRC President of the Bloemfontein Campus and leader of the UFS Safety Champions that form part of the Unit for Institutional Change and Social Justice.

Luwaca further said that the Mangaung Metropolitan Municipality also committed to assist the universities in addressing crime and enforcing by-laws. “A strategic safety plan was developed around spatialisation and zoning of student communes, developing a system that will assist universities to establish where students stay by using technology such as geographic information system (GIS),” he added.

What were the objectives of the summit?
Being the first of many to come, the summit set out clear objectives which all stakeholders have committed to work tirelessly to achieve, both in the short and long term.

The goals of the summit were threefold. Firstly, the intention was to build capacity between students and staff of all institutions involved to implement programmes by transferring the skills and knowledge between one another.

Secondly, the idea was to gather and consolidate input from the various higher-learning institutions and by so doing diversify the solutions. Thirdly, the purpose of the summit was to create an official platform where partners may consult on interventions that will ripple from the local, to the provincial and further to national level.

Andiswa Msomi, Spatialisation Group Leader and the Safety Champions’ administrator said she appreciated the shift in perspective that the summit brought. “The summit brought to my attention that sometimes we focus so deeply on one aspect of a problem that we end up not seeing alternative solutions. Due to active participants, new solutions came up, new ideas were brought forth and more importantly, we were able to get other institutions on board,” she said.

What are some of the tangible outcomes?
Going forward, an internal report which focuses on crime prevention measures will be presented to all UFS stakeholders. An external report, which will be submitted by the Safety Champions to the government in January 2020, is expected to be integrated into the Provincial Crime Prevention Strategy.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept